Valuation: InMode Ltd.

Market Cap 868M 754M 700M 645M 1.22B 82.84B 1.24B 8.29B 3.24B 41.14B 3.26B 3.19B 138B P/E 2026 *
13.1x
P/E 2027 * 11.8x
Enterprise Value 868M 754M 700M 645M 1.22B 82.84B 1.24B 8.29B 3.24B 41.14B 3.26B 3.19B 138B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.29x
Free-Float
60.55%
Yield 2026 *
-
Yield 2027 * -
1 day-0.36%
1 week+0.03%
Current month+3.25%
1 month+3.25%
3 months+4.32%
6 months-3.91%
Current year+2.76%
1 week 14.94
Extreme 14.94
15.6
1 month 14.4
Extreme 14.4
15.67
Current year 12.72
Extreme 12.72
16.67
1 year 12.72
Extreme 12.72
16.74
3 years 12.72
Extreme 12.72
44.41
5 years 12.72
Extreme 12.72
99.27
10 years 6.53
Extreme 6.53
99.27
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2008
Chief Executive Officer 73 01/01/2008
Director of Finance/CFO 41 18/05/2026
Director TitleAgeSince
Chairman 73 01/01/2008
Director/Board Member 59 06/08/2019
Chairman 67 04/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%+0.03%+8.60%-64.77% 868M
+0.05%+0.78%+20.85%+2.66% 214B
-0.16%+1.91%-3.83%-24.57% 138B
-0.04%+6.31%-29.48%+8.10% 125B
-0.09%+5.55%-56.91%-11.01% 68.37B
+1.35%+3.70%+7.10%+3.80% 50.05B
-0.91%+9.32%-24.83%-29.30% 47.67B
-1.13%-0.74%+17.50%+10.04% 39.18B
+0.22%-0.55%+27.16%+33.08% 37.34B
-2.73%+12.82%-2.37%-10.18% 31.59B
Average -0.38%+6.37%-3.62%-8.22% 75.2B
Weighted average by Cap. -0.16%+7.50%-3.76%-3.35%

Financials

2026 *2027 *
Net sales 370M 322M 299M 275M 519M 35.35B 528M 3.54B 1.38B 17.56B 1.39B 1.36B 59.04B 379M 329M 306M 282M 531M 36.18B 541M 3.62B 1.42B 17.97B 1.42B 1.39B 60.43B
Net income 72.86M 63.29M 58.77M 54.2M 102M 6.96B 104M 696M 272M 3.45B 274M 268M 11.62B 78.41M 68.1M 63.24M 58.33M 110M 7.49B 112M 749M 293M 3.72B 294M 288M 12.5B
Net Debt - -
Logo InMode Ltd.
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Employees
660
Date Price Change Volume
30/07/26 US$15.10 -0.36% 682,333
29/07/26 US$15.15 -2.07% 866,663
28/07/26 US$15.47 +0.59% 586,145
27/07/26 US$15.38 +1.38% 688,606
24/07/26 US$15.17 +0.53% 419,196
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
15.10USD
Average target price
15.33USD
Spread / Average Target
+1.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INMD Stock